Cargando…
No Durable Impact of COVID-19 on Intestinal Disease Activity in Subjects With IBD
Autores principales: | Lukin, Dana J., Funez-dePagnier, Gabriela, Lima, Svetlana, Lai, Daniel, Duenas-Bianchi, Lucia, Ahmed, Waseem, Jacob, Vinita, Battat, Robert, Scherl, Ellen, Longman, Randy S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the AGA Institute
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178538/ https://www.ncbi.nlm.nih.gov/pubmed/34102340 http://dx.doi.org/10.1016/j.cgh.2021.06.008 |
Ejemplares similares
-
Impact of Inflammatory Bowel Disease Therapies on Durability of Humoral Response to SARS-CoV-2 Vaccination
por: Charilaou, Paris, et al.
Publicado: (2022) -
Su1487: IMPACT OF INFLAMMATORY BOWEL DISEASE THERAPIES ON DURABILITY OF HUMORAL RESPONSE TO SARS COV-2 VACCINATION
por: Charilaou, Paris, et al.
Publicado: (2022) -
Joint Disease Activity in Inflammatory Bowel Disease–associated Peripheral Spondyloarthritis Stratifies Therapeutic Response
por: LAI, D., et al.
Publicado: (2022) -
Patient-Preferences Favoring Treatment Discontinuation Are Reduced With Vedolizumab and Ustekinumab Compared With TNF Antagonists in Inflammatory Bowel Disease
por: Kumar, Anand, et al.
Publicado: (2020) -
Defining the phenotype, pathogenesis and treatment of Crohn’s disease associated spondyloarthritis
por: Kumar, Anand, et al.
Publicado: (2020)